Equalize 2021 pitch competition will be presented via Zoom on September 22, 2021
Noon — 5 p.m. (CST)
| Time | Description |
|---|---|
| Noon | Keynote and Q&A: “The State of Women Inventors in America” Elizabeth Dougherty, United States Patent & Trademark Office |
| 12:45 p.m. | Welcome Remarks & Introductions Nichole Mercier, Washington University in St. Louis Kirsten Leute, Osage University PartnersPitch Competition 12 pitches, 10 minutes each with 5-minute Q&A with judges 6 pitches in Diagnostics & Medical Devices 6 pitches in Therapeutics |
| 12:50 p.m. | Reetuparna Das University of Michigan Startup: Sequal Technology: Ultra-rapid molecular diagnosis of cancer |
| 1:05 p.m. | Melanie Joy University of Colorado Startup: Katharos, Inc. Technology: Extracorporeal device for optimizing phosphate control in hemodialysis |
| 1:20 p.m. | 5-minute BREAK |
| 1:25 p.m. | Sunyoung Kim Louisiana State University School of Medicine & Health Sciences Center Startup: Chosen Diagnostics Inc. Technology: Biomarker panel to improve necrotizing enterocolitis diagnosis |
| 1:40 p.m. | Kacey Marra University of Pittsburgh Startup: AxoMax Technologies, Inc. Technology: Biodegradable nerve guide |
| 1:55 p.m. | 5-minute BREAK |
| 2 p.m. | Sarah Vigmostad The University of Iowa Startup: SynderBio, Inc. Technology: Novel, high-throughput cell separation techniques for single cell sequencing and cancer diagnosis |
| 2:15 p.m. | Pamela Woodard Washington University in St. Louis Startup: GwynTech Technology: AtheroBrite |
| 2:30 p.m. | 15-minute BREAK |
| 2:45 p.m. | Alexis Demonbreun Northwestern University Startup: Ikaika Therapeutics Technology: Genetic modifiers of muscle disease as therapeutic targets |
| 3 p.m. | Barbara Ehrlich Yale University Startup: Center Pharm Technology: A new target for treatment of Wolfram Syndrome |
| 3:15 p.m. | 5-minute BREAK |
| 3:20 p.m. | Yiping Han Columbia University Technology: Novel therapeutics to treat familial adenomatous polyposis (FAP) |
| 3:35 p.m. | Sandhya Kortagere Drexel University Technology: A disease modifying and neuroprotective agent to treat Parkinson’s disease |
| 3:50 p.m. | 5-minute BREAK |
| 3:55 p.m. | Martina Roos University of California, Los Angeles Startup: Sardona Therapeutics Technology: Small molecules targeting RNA regulators in cancer stem cells |
| 4:10 p.m. | Judith Sebolt-Leopold University of Michigan Startup: Mekanistic Therapeutics Technology: A first-in-class therapeutic targeting deregulation of EGFR and PI3K |
| 4:25 p.m. | Closing remarks |
| 4:35 p.m. | Announce awards |
| 5 p.m. | End |